Now showing items 1-2 of 2
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
(American Academy of Neyurology, 2009)
Background: The frequency of HIV dementia in a recent study of HIV individuals at the Infectious Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include stavudine, are the most common ...
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
(American Academy of Neurology, 2007)
Objective: To measure the frequency and associated risk factors of HIV dementia in an HIV clinic in Kampala, Uganda. Methods: We systematically sampled 78 HIV-seropositive (HIV ) patients from an ambulatory HIV ...